Dear Friends and Colleagues,
Cardiovascular Disease remain the leading cause of morbidity and mortality in developed and
developing countries although tremendous progress has been reached in the last years concerning
the prevention, the understanding of pathophysiology, the diagnostic methods, noninvasive
and invasive therapy.
This “International Congress of Cardiology: from Scientic Research to Clinical Practice” aim to
discuss with an excellent Faculty of national and international scientists from different European
countries as well as from USA and Asia, modern aspects in pathophysiology, diagnosis and
treatment of different cardiovascular diseases: relevant aspects concerning molecular alterations
of troponin in Cardiomyopathies and the progress of high resolution MRI for the diagnosis of this
pathology; the continuum from ventricular dysfunction to Heart Failure, the relation with sleep
disorders and the new ESC guidelines on Heart Failure.
The ESC Guidelines 2016 on Atrial Fibrillation will be discussed analyzing the new pathogenic
hypothesis on atrial brillation, the pro and contra of cardioversion versus ablation to restore
sinus rhythm and the relevant role of new oral anticoagulant in preventing systemic embolism
The added contribution of strain in echocardiography in different form of cardiopathy
(cardiomyopathy, Valvulopathies, dilated cardiomyopathy, arrhythmias) will be discussed.
Cardio-oncology is a new branch of cardiology deriving from the close cooperation of cardiologist
and oncologist in the study of cardiac and vascular complication of new anticancer drugs
in this pathology second only to cardiovascular disease for morbidity and mortality. New drugs
to treat cancer often determine a cardiac damage and only the use of biomarkers and imaging
technique, in particular global longitudinal strain reduction and cardiac MRI, may consent a
precocious diagnosis of heart failure and vascular damage to start a preventive therapy as
evidenced in the 2016 Position Paper of the ESC on Cardio-Oncology.
Finally will be discussed the relationship between Cardiometabolic risk and Cardio-vascular
events also considering the new Guidelines ESC 2016 in Cardiovascular Prevention.
We hope that the Congress will consent an interesting change of ideas and an interactive
discussion with Italian cardiologists and, of course, we believe that outside from congress works,
all participants may enjoy to visit Palermo, one of the Mediterranean town richer in culture and
different historical sites.